Comparison of the efficacy of narrow band ultraviolet B and narrow band ultraviolet B plus topical catalase-superoxide dismutase treatment in vitiligo patients

European Journal of Dermatology

Volumn 19, Issue 4, 2009, Pages 341-344

  Yuksel, Esra Pancar ^a   Aydin, Fatma ^a   Senturk, Nilgun ^a   Canturk, Tayyar ^a   Turanli, Ahmet Yasar ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Catalase superoxide dismutase; Narrow band ultraviolet B; Vitiligo

Indexed keywords

ANTIOXIDANT; CATALASE PLUS SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; VITIX;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; SKIN DEFECT; TREATMENT RESPONSE; ULTRAVIOLET B RADIATION; VITILIGO;

ADMINISTRATION, TOPICAL; ADULT; CATALASE; FEMALE; HUMANS; MALE; STATISTICS, NONPARAMETRIC; SUPEROXIDE DISMUTASE; TREATMENT OUTCOME; ULTRAVIOLET THERAPY; VITILIGO;

EID: 67650866293     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2009.0699     Document Type: Article

References (19)

1. Ortonne JP. Vitiligo and other disorders of hypopigmentation. In: Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology. Toronto: Elsevier, 2003: 947-973
2. Koca R, Armutcu F, Altinyazar HC, Gürel A. Oxidant-antioxidant enzymes and lipid peroxidation in generalized vitiligo. Clin Exp Dermatol 2004; 29: 406-409 (Pubitemid 38980375)
3. 2 and pterin-6-carboxylic acid. Biochem Biophys Res Comm 2002; 292: 805-811
4. Picardo M, Passi S, Morrone A, Grandinetti M, Di Carlo A, Ippolito F. Antioxidant status in the blood of patients with active vitiligo. Pigment Cell Res 1994; 7: 110-115
5. Nicolaidou E, Antoniou C, Stratigos AJ, Stefanaki C, Katsambas AD. Efficacy, predictors of response, and long-term follow-up in patients with vitiligo treated with narrowband UVB phototherapy. J Am Acad Dermatol 2007; 56: 274-278 (Pubitemid 46074252)
6. Goktas EO, Aydin F, Senturk N, Canturk MT, Turanli AY. Combination of narrow band UVB and topical calcipotriol for the treatment of vitiligo. J Eur Acad Dermatol Venereol 2006; 20: 553-557
7. Aydin F, Senturk N, Sahin B, Bek Y, Yuksel EP, Turanli AY. A practical method for the estimation of vitiligo surface area: a comparison between the point counting and digital planimetry techniques. Eur J Dermatol 2007; 17: 30-32 (Pubitemid 46383217)
8. Yildirim M, Baysal V, Inaloz HS, Can M. The role of oxidants and antioxidants in generalized vitiligo at tissue level. J Eur Acad Dermatol Venereol 2004; 18: 683-686 (Pubitemid 39429707)
9. Schallreuter KU, Wood JM, Berger J. Low catalase levels in the epidermis of patients with vitiligo. J Invest Dermatol 1991; 97: 1081-1085
10. Medrano EE, Nordlund JJ. Successful culture of adult human melanocytes obtained from normal and vitiligo donors. J Invest Dermatol 1990; 95: 441-445
11. 2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. J Investig Dermatol Symp Proc 1999; 4: 91-96
12. Schallreuter KU. Successful treatment of oxidative stress in vitiligo. Skin Pharmacol Appl Skin Physiol 1999; 12: 132-138 (Pubitemid 29313292)
13. Schallreuter KU, Moore J, Behrens-Williams S, Panske A, Harari M. Rapid initiation of repigmentation in vitiligo with Dead Sea climatotherapy in combination with pseudocatalase (PC-KUS). Int J Dermatol 2002; 41: 482-487 (Pubitemid 35021486)
14. Schallreuter KU, Wood JM, Lemke KR, Levenig C. Treatment of vitiligo with a topical application pseudocatalase and calcium in combination with short term UVB exposure: A case study on 33 patients. Dermatology 1995; 190: 223-229
15. Patel DC, Evans AV, Hawk JL. Topical pseudocatalase mousse and narrowband UVB phototherapy is not effective for vitiligo: an open, single-centre study. Clin Exp Dermatol 2002; 27: 641-644
16. Schallreuter KU. Effectiveness of pseudocatalase formulation in vitiligo. Clin Exp Dermatol 2003; 28: 562-563
17. Schallreuter KU, Rokos H. Vitix-a new treatment for vitiligo? Int J Dermatol 2005; 44: 969-970
18. Kostovic K, Pastar Z, Pasic A, Ceovic R. Treatment of vitiligo with narrow-band UVB and topical gel containing catalase and superoxide dismutase. Acta Dermatovenerol Croat 2007; 15: 10-14 (Pubitemid 46649166)
19. De Francesco V, Stinco G, Laspina S, Parlangeli ME, Mariuzzi L, Patrone P. Immunohistochemical study before and after narrow band (311 nm) UVB treatment in vitiligo. Eur J Dermatol 2008; 18: 292-296 (Pubitemid 351821232)